Rundhaug J E, Gimenez-Conti I, Stern M C, Budunova I V, Kiguchi K, Bol D K, Coghlan L G, Conti C J, DiGiovanni J, Fischer S M, Winberg L D, Slaga T J
The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville 78957, USA.
Mol Carcinog. 1997 Sep;20(1):125-36.
To directly compare the expression patterns of different proteins known to be altered during mouse skin carcinogenesis, serial sections of normal and hyperplastic skin and tumors from various stages of 7,12-dimethylbenz[a]anthracene-initiated, 12-O-tetradecanoylphorbol-13-acetate-promoted female SENCAR mice were examined by immunohistochemistry. In untreated, normal mouse skin, keratin 1 (K1) and transforming growth factor-beta1 (TGFbeta1) were strongly expressed in the suprabasal layers, whereas integrin alpha6beta4 was expressed only in basal cells and only moderate staining for transforming growth factor-alpha (TGFalpha) was seen. In hyperplastic skin, TGFalpha expression became stronger, whereas expression of another epidermal growth factor (EGF) receptor ligand, heparin-binding EGF-like growth factor (HB-EGF), was strongly induced in all epidermal layers from no expression in normal skin. Likewise, the gap-junctional protein connexin 26 (Cx26) became highly expressed in the differentiated granular layers of hyperplastic skin relative to undetectable expression in normal skin. Expression of cyclin D1 in the proliferative cell compartment was seen in all benign and malignant tumors but not in hyperplastic skin. Beginning with very early papillomas (after 10 wk of promotion), expression of alpha6beta4 in suprabasal cells and small, focal staining for keratin 13 (K13) were seen in some tumors. Later (after 20-30 wk), focal areas of gamma-glutamyl transpeptidase (GGT) activity appeared in a few papillomas, whereas TGFbeta1 expression began to decrease. Cx26 and TGFalpha staining became patchier in some late-stage papillomas (30-40 wk), whereas suprabasal alpha6beta4, K13, and GGT expression progressively increased and K1 expression decreased. Finally, in squamous cell carcinomas (SCCs), there was an almost complete loss of K1 and a further decline in TGFalpha, HB-EGF, TGFbeta1, and Cx26 expression. On the other hand, almost all SCCs showed suprabasal staining for alpha6beta4 and widespread cyclin D1 and K13 expression, whereas only about half showed positive focal staining for GGT activity.
为了直接比较已知在小鼠皮肤癌发生过程中发生改变的不同蛋白质的表达模式,我们通过免疫组织化学检查了7,12-二甲基苯并[a]蒽引发、12-O-十四烷酰佛波醇-13-乙酸酯促进的雌性SENCAR小鼠不同阶段的正常、增生性皮肤和肿瘤的连续切片。在未处理的正常小鼠皮肤中,角蛋白1(K1)和转化生长因子-β1(TGFβ1)在上基底层强烈表达,而整合素α6β4仅在基底细胞中表达,转化生长因子-α(TGFα)仅见中度染色。在增生性皮肤中,TGFα表达变强,而另一种表皮生长因子(EGF)受体配体,即肝素结合表皮生长因子样生长因子(HB-EGF),在正常皮肤中无表达,而在所有表皮层中强烈诱导表达。同样,缝隙连接蛋白连接蛋白26(Cx26)在增生性皮肤的分化颗粒层中高度表达,而在正常皮肤中未检测到表达。细胞周期蛋白D1在增殖细胞区室中的表达在所有良性和恶性肿瘤中均可见,但在增生性皮肤中未见。从非常早期的乳头状瘤(促癌10周后)开始,在一些肿瘤中可见上基底层细胞中α6β4的表达以及角蛋白13(K13)的小灶性染色。后来(20 - 30周后),一些乳头状瘤中出现了γ-谷氨酰转肽酶(GGT)活性的局灶性区域,而TGFβ1表达开始下降。在一些晚期乳头状瘤(30 - 40周)中,Cx26和TGFα染色变得更斑驳,而上基底层α6β4、K13和GGT表达逐渐增加,K1表达下降。最后,在鳞状细胞癌(SCC)中,K1几乎完全缺失,TGFα、HB-EGF、TGFβ1和Cx26表达进一步下降。另一方面,几乎所有SCC均显示上基底层α6β4染色以及广泛的细胞周期蛋白D1和K13表达,但只有约一半显示GGT活性的阳性局灶性染色。